New York State Common Retirement Fund’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31K Hold
28,015
﹤0.01% 3057
2025
Q1
$22K Hold
28,015
﹤0.01% 2960
2024
Q4
$46K Hold
28,015
﹤0.01% 2873
2024
Q3
$98K Hold
28,015
﹤0.01% 2593
2024
Q2
$92K Buy
28,015
+20
+0.1% +$66 ﹤0.01% 2903
2024
Q1
$205K Sell
27,995
-30
-0.1% -$220 ﹤0.01% 2426
2023
Q4
$105K Sell
28,025
-168
-0.6% -$629 ﹤0.01% 2731
2023
Q3
$60K Buy
28,193
+286
+1% +$609 ﹤0.01% 2956
2023
Q2
$133K Sell
27,907
-76
-0.3% -$362 ﹤0.01% 2670
2023
Q1
$160K Sell
27,983
-42,945
-61% -$246K ﹤0.01% 2682
2022
Q4
$716K Sell
70,928
-4,466
-6% -$45.1K ﹤0.01% 2143
2022
Q3
$1.69M Buy
75,394
+6,486
+9% +$145K ﹤0.01% 1697
2022
Q2
$1.71M Buy
68,908
+664
+1% +$16.5K ﹤0.01% 1743
2022
Q1
$2.65M Buy
68,244
+5,910
+9% +$229K ﹤0.01% 1604
2021
Q4
$3.65M Buy
62,334
+4,386
+8% +$257K ﹤0.01% 1453
2021
Q3
$3.44M Sell
57,948
-22,819
-28% -$1.35M ﹤0.01% 1471
2021
Q2
$7.01M Buy
80,767
+7,322
+10% +$635K 0.01% 1186
2021
Q1
$6.06M Buy
73,445
+8,845
+14% +$729K 0.01% 1177
2020
Q4
$5.87M Buy
64,600
+3,400
+6% +$309K 0.01% 1195
2020
Q3
$2.45M Buy
61,200
+3,700
+6% +$148K ﹤0.01% 1470
2020
Q2
$1.97M Buy
57,500
+2,900
+5% +$99.5K ﹤0.01% 1541
2020
Q1
$1.21M Hold
54,600
﹤0.01% 1645
2019
Q4
$1.07M Buy
54,600
+1,000
+2% +$19.6K ﹤0.01% 1923
2019
Q3
$832K Hold
53,600
﹤0.01% 2073
2019
Q2
$1.09M Sell
53,600
-38,690
-42% -$785K ﹤0.01% 1966
2019
Q1
$1.62M Buy
92,290
+39,890
+76% +$701K ﹤0.01% 1714
2018
Q4
$672K Hold
52,400
﹤0.01% 2134
2018
Q3
$854K Hold
52,400
﹤0.01% 2178
2018
Q2
$594K Buy
52,400
+11,900
+29% +$135K ﹤0.01% 2377
2018
Q1
$395K Hold
40,500
﹤0.01% 2455
2017
Q4
$247K Hold
40,500
﹤0.01% 2656
2017
Q3
$160K Hold
40,500
﹤0.01% 2881
2017
Q2
$131K Buy
+40,500
New +$131K ﹤0.01% 3029